Site Reference ID/Investigator# 2614 — New York, New York

Site Reference ID/Investigator# 2614 is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 2614 has participated in 1 clinical trials.

Therapeutic areas: Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma.

Sponsors: AbbVie (prior sponsor, Abbott).

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 2614?

Site Reference ID/Investigator# 2614 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 2614 conducted?

Site Reference ID/Investigator# 2614 has 1 clinical trials on record. Their work covers Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma.

Is Site Reference ID/Investigator# 2614 accredited by Crixeo Health?

Site Reference ID/Investigator# 2614 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 2614?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.